SCHEMBL21671865

SCHEMBL21671865

O=C1CCc2ccc(Br)nc2N1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
NPC1 O15118 1/20 0.40
MAPK13 O15264 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
CA9 Q16790 1/20 0.40
DRD2 P14416 11/20 0.37
HTR1A P08908 10/20 0.37
HTR2A P28223 10/20 0.37
CRBN Q96SW2 2/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
SRD5A1 P18405 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31220098 0.83 AHR (0.46) PDE3BPDE3A
SCHEMBL5366571 0.78 CA9 (0.47) PDE3BPDE3ANPC1MAPK13MAPK12
SCHEMBL29809401 0.78 PDE3B (0.50) PDE3BPDE3ANPC1MAPK13MAPK12
SCHEMBL18202413 0.78 PDE3B (0.43) PDE3BPDE3ANPC1MAPK13MAPK12
SCHEMBL4148301 0.78 PDE3B (0.43) PDE3BPDE3ANPC1MAPK13MAPK12
SCHEMBL4132924 0.78 PDE3B (0.50) PDE3BPDE3ANPC1MAPK13MAPK12
SCHEMBL5371747 0.78 PDE3B (0.43) PDE3BPDE3ANPC1MAPK13MAPK12
SCHEMBL13111251 0.77 PDE3B (0.43) PDE3BPDE3ANPC1MAPK13MAPK12
SCHEMBL335438 0.77 DRD2 (0.49) PDE3BPDE3ADRD2HTR1AHTR2A
SCHEMBL3153757 0.75 PDE3B (0.41) PDE3BPDE3ANPC1MAPK13MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3604306-A1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai de Novo Pharmatech Co., Ltd. (CN) 2020-02-05 EP disclosed